Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/15/23
End: 11/15/27
Due: 11/15/28
Phase: N/A
Priority: Normal
Start: 07/04/23
End: 06/15/26
Due: 06/15/27
Phase: N/A
Priority: Normal
Start: 06/09/21
End: 11/30/23
Due: 11/30/24
Phase: N/A
Priority: Normal
Start: 02/28/22
End: 05/31/24
Due: 05/31/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer | NCT05794659 | Aston Sci. Inc. | user2@example.com | None | 2023-11-15 | 2027-11-15 | 2028-11-15 | - | - | 2025-07-14 |
| Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Gastric Cancer | NCT05771584 | Aston Sci. Inc. | user2@example.com | None | 2023-07-04 | 2026-06-15 | 2027-06-15 | - | - | 2025-07-14 |
| AST-021p Study in Advanced Solid Tumors | NCT04864418 | Aston Sci. Inc. | user2@example.com | None | 2021-06-09 | 2023-11-30 | 2024-11-30 | - | - | 2025-07-14 |
| Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer | NCT05163223 | Aston Sci. Inc. | user2@example.com | None | 2022-02-28 | 2024-05-31 | 2025-05-31 | - | - | 2025-07-14 |